/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $547.6 billion, Johnson & Johnson (JNJ) is a global healthcare company engaged in the research, development, manufacturing, and sale of a wide range of medical products worldwide. Through its Innovative Medicine and MedTech segments, the company delivers therapies and technologies spanning immunology, oncology, cardiovascular care, neuroscience, surgery, orthopaedics, vision care, and other critical healthcare areas.
Shares of the New Brunswick, New Jersey-based company have outperformed the broader market over the past 52 weeks. JNJ stock has climbed 50.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 15.4%. Moreover, JNJ stock has returned 9.8% on a YTD basis, compared to SPX's 1.8% rise.
